Elizabeth Ann Eisenhauer, O.C.
Kingston, Ontario
Elizabeth Eisenhauer is an international leader in clinical cancer research. Professor emerita at Queen’s University and former director of the Canadian Cancer Trials Group investigational drug program, she has played an influential role in helping shape cancer treatment through key advancements in clinical trials. Notably, she led the design of criteria to evaluate the response of tumours to therapy, and evaluated numerous new drugs now used routinely in cancer treatment. Renowned for her experience and expertise, she has served on numerous international professional and institutional committees, benefiting oncology research worldwide.